Acorda Therapeutics, Inc.
SUSTAINED RELEASE COMPOSITIONS OF 4-AMINOPYRIDINE
Last updated:
Abstract:
The present invention generally relates to sustained release 4-aminopyridine tablets, which include a core and a coating. The sustained release tablets of the invention are generally suitable for once daily oral administration for the treatment of neurological disorders.
Status:
Application
Type:
Utility
Filling date:
4 Dec 2020
Issue date:
25 Mar 2021